Author:
Jiang Tao,Qiao Meng,Zhou Fei,Ren Shengxiang,Su Chunxia,Zhou Caicun
Funder
National Natural Science Foundation of China
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference43 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004
3. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat Rev Cancer,2014
4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009
5. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol,2011
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献